​Quality in Teva medicines is paramount at all phases of the product lifecycle.

Quality supervision begins at the test facilities with careful documentation and general conduct of non-clinical safety studies. This ensures compliance with current Good Laboratory Practice (GLP) and consequently, the integrity of the data produced. It then follows through clinical trials, production and distribution, and concludes with shelf-life surveillance.

During clinical stage development, quality supervision guarantees that the fundamentals of current Good Manufacturing Practices (cGMPs) are consistently applied. Quality is built into the different phases of clinical development to secure the safety and rights of our studies’ participants, the reliability of the data submitted to health authorities, and the complete adherence to all current Good Clinical Practices (GCPs).

Teva has state-of-the-art manufacturing facilities, uses advanced testing instrumentation and follows current Good Manufacturing Practices (cGMPs) to guarantee the quality of its products. Teva additionally supervises suppliers' procedures in order to ensure that quality materials are used in its products. Once a product gains regulatory approval and enters routine manufacturing, quality is guaranteed throughout the process, for both active and inactive ingredients and finished dosage pharmaceutical products.

Quality doesn't end when the product is released.  Product is shipped following the principles of current Good Distribution Practices (cGDPs) & Teva continues to monitor its products throughout their shelf life. Representative batches of all products are checked for stability to ensure that products remain safe and effective throughout their shelf life. Teva addresses and responds to quality and medical complaints. Information about potential quality or medical issues is shared throughout the Teva network, and appropriate actions are taken.


If you wish to report a complaint about a Teva product that you or someone you know is using, please contact us at Quality.Australia@tevapharm.com or 1800 AU TEVA (1800 28 8382) and we will commence an investigation.